News & Views: Test Yourself on the Findings of the 2019 NIS and NIS-Teen
Published on in Vaccine Update for Healthcare Providers
Published on in Vaccine Update for Healthcare Providers
During the COVID-19 pandemic, the Centers for Disease Control and Prevention (CDC) released the National Immunization Survey (NIS) and NIS-Teen data. Because of the stay-at-home orders earlier in 2020, most recently, we have all been hearing and thinking about how to recover immunization rates, which fell precipitously (See these MMWR publications from May 15, 2020 and May 22, 2020 for more information). As such, some people may have missed the NIS and NIS-Teen publications.
While recovering immunization rates is critical, we cannot forget what these important data show related to immunization rates prior to the pandemic. See how you do answering the following questions that highlight some of the findings.
Answer: B. While improvements since the last NIS were observed with two-dose coverage of influenza vaccine (from 53.8% to 58.1%), this vaccine still had the lowest coverage rates. Further, the authors pointed out that since the NIS measures immunization coverage through 24 months of age, many children would technically have been recommended to receive three doses (two doses separated by one month in the first year and one dose in the second year); therefore, coverage rates were likely lower than the estimates presented in the report.
Answer: C. Co-circulation of influenza and SARS-CoV-2 viruses, both of which can cause severe illness and death, may strain public health and medical systems throughout the U.S.
Answer: A. The average rate of unvaccinated children was 1.2%, which has ranged from 0.9% to 1.5% in NIS surveys of children born between 2011 and 2017.
Answer: D. About 4 of 100 children without insurance coverage had not received any vaccines, compared with 1 to 2 of 100 children with any type of insurance.
Check out the complete set of NIS findings.
Answer: C. While rates of meningococcal B vaccination improved from 17.2% to 21.8%, the reality is that only 2 of 10 adolescents are being actively protected against the potentially deadly disease caused by meningococcal type B.
Answer: A. Only 53.7% of 17-year-old teens surveyed had received at least two doses of meningococcal ACWY, and only 54.2% of 13- to 17-year-olds surveyed were considered up to date on HPV vaccine.
Answer: D. All of the ideas listed were considered to be contributing factors to improving HPV vaccination by 13 years of age.
Answer: E. All of these recommendations were made for healthcare providers to ensure that adolescents are up to date on vaccinations.
Contributed by: Charlotte A. Moser, MS, Paul A. Offit, MD
Categories: Vaccine Update November 2020, News and Views About Vaccines
Materials in this section are updated as new information and vaccines become available. The Vaccine Education Center staff regularly reviews materials for accuracy.
You should not consider the information in this site to be specific, professional medical advice for your personal health or for your family's personal health. You should not use it to replace any relationship with a physician or other qualified healthcare professional. For medical concerns, including decisions about vaccinations, medications and other treatments, you should always consult your physician or, in serious cases, seek immediate assistance from emergency personnel.